Pages that link to "Q42661083"

The following pages link to A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease (Q42661083):

Displaying 19 items.

• Social Determinants of Racial Disparities in CKD. (Q30250319) (← links)
• Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis. (Q30251636) (← links)
• Safety of ACE inhibitor therapies in patients with chronic kidney disease (Q34434606) (← links)
• Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris (Q34566315) (← links)
• Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects? (Q34738508) (← links)
• Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset (Q35025425) (← links)
• Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies. (Q35085669) (← links)
• Calcium channel blockers in the prevention of end stage renal disease: a review (Q35738806) (← links)
• RAS inhibition in hypertension (Q36362382) (← links)
• The CARI guidelines. Prevention of progression of kidney disease: autosomal-dominant polycystic kidney disease. (Q36742529) (← links)
• Calcium antagonists and renal failure progression. (Q37113512) (← links)
• The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review (Q38050872) (← links)
• Dihydropyridine calcium channel blockers and renal disease (Q38895879) (← links)
• Prevalence of chronic renal failure in primary care (Q43885926) (← links)
• Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis (Q47125921) (← links)
• Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate (Q90158237) (← links)
• Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease (Q90752374) (← links)
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (Q92377672) (← links)
• Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials (Q92861312) (← links)